Rejected
at 4:01 a.m. Nov, 01, 2023 ]
by
Cameron
Author:
GroupG_Strep93
Type of change:
Updated content
Rationale for change
AMBOSS confirms it is a general LT-receptor antagonists. LTD4 is the most potent, but not the only LT that causes bronchoconstriction
Source: AMBOSS - https://next.amboss.com/us/article/Ph0WVf?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=montelukast&guid=s%2523Clb%253FtghU&aid=1e65b2b7-5610-440d-8bf5-8fed592492a8&uid=fRyXkmU00#Z285b08d7b8f9a0c375a695a4e1578297
Rejection reason
Zafirlukast kits D4 and E4 but montelukast only hits D4; According to AMBOSS' specific drug pages for each
Current
Suggested
Text
Text
Text
Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
OME
Additional Resources
One by one
Empty field